CorMedix Inc. (CRMD)
| Market Cap | 571.13M-34.4% |
| Revenue (ttm) | n/a+280.5% |
| Net Income | n/a+265.9% |
| EPS | n/a+182.9% |
| Shares Out | 78.45M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 832,890 |
| Open | 7.27 |
| Previous Close | 7.28 |
| Day's Range | 7.18 - 7.31 |
| 52-Week Range | 6.13 - 13.02 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 14.50(+99.18%) |
| Earnings Date | n/a |
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About CRMD
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CRMD stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in CRMD holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CRMD's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CRMD Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New CRMD patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CRMD from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CRMD
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $18.40M |
| AVUVAvantis U.S. Small Cap Value ETF | $16.05M |
| IWMiShares Russell 2000 ETF | $14.31M |
| VXFVanguard Extended Market ETF | $6.98M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | $5.99M |
| VIRSPacer BioThreat Strategy ETF | $4.93M |
Estimated from each fund’s disclosed top holdings × AUM
CRMD Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CRMD’s recent data — informational, not investment advice